Photo of Tracey Mann
R United States House · District 1 · Kansas On the 2026 ballot

Rep. Tracey Mann

Compare
Total votes
2,818
all sessions
Attendance
100%
5 missed
Higher than 97% of chamber peers
With party
94%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
1,259
bills & resolutions
Near the chamber average
Committees
8
assignments
1,259 bills and resolutions

Sponsored bills

Total
1,259
Primary
76
Co-sponsor
1,183
This page
1,259
matching current filters
Primary HR 714
In committee · Delaware House · Lead sponsor
To promote accountability and transparency in future executive orders.

This bill requires the President to provide Congress with certain information at least 30 days before issuing an executive order related to abortion. Before issuing an abortion-related executive order, the President shall provide Congress with (1) the executive order text, (2) a list of the federal laws affected, (3) information about how the President is working within the parameters of federal law and the Constitution, (4) information about how the executive order will be accomplished, and (5) a list of all the individuals and entities that the President engaged with before issuing the order.

In committee Feb 3, 2021 0 co-sponsors
Co-sponsor HRES 81
In committee · Delaware House · Co-sponsor
Expressing the opposition of the House of Representatives of providing the vaccination for COVID-19 for detainees at the detention facility at United States Naval Station, Guantanamo Bay, Cuba, before American citizens receive such vaccination.

This resolution expresses the opposition of the House of Representatives to any plans by the Department of Defense to deliver COVID-19 (i.e., coronavirus disease 2019) vaccines to prisoners held at United States Naval Station, Guantanamo Bay, Cuba, until all Americans have had the opportunity to be vaccinated. Additionally, the resolution asserts that the government should prioritize U.S. citizens for COVID-19 vaccinations.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 682
In committee · Delaware House · Co-sponsor
Reopen Schools Act

Reopen Schools Act This bill requires a local educational agency (LEA) to reopen its elementary and secondary schools as a condition for receiving certain supplemental education emergency relief funding. Specifically, an LEA must provide in-person instruction to at least 50% of its students in order to receive the full funding. An LEA that provides in-person instruction to at least some of its students shall have its funding reduced on a pro rata basis.

In committee Feb 2, 2021 1 co-sponsor
Primary HR 713
In committee · Delaware House · Lead sponsor
To promote accountability and transparency in future executive orders.

This bill requires the President to provide Congress with certain information at least 30 days before issuing an executive order related to agriculture, food, and the livelihood of farmers, ranchers, and producers in the United States. Before issuing such an order, the President shall provide Congress with (1) the executive order text, (2) a list of the federal laws affected, (3) information about how the President is working within the parameters of federal law and the Constitution, (4) information about how the executive order will be accomplished, and (5) a list of all the individuals and entities that the President engaged with before issuing the order.

In committee Feb 2, 2021 0 co-sponsors
Co-sponsor HR 695
In committee · Delaware House · Co-sponsor
USPS Fairness Act

USPS Fairness Act This bill repeals the requirement that the U.S. Postal Service annually prepay future retirement health benefits.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 648
In committee · Delaware House · Co-sponsor
Ultrasound Informed Consent Act

Ultrasound Informed Consent Act This bill requires abortion providers to conduct an ultrasound before performing an abortion. Specifically, before a woman gives informed consent to any part of an abortion, the abortion provider must perform an obstetric ultrasound on the pregnant woman; provide a simultaneous explanation of what the ultrasound is depicting; display the ultrasound images so the woman may view them; and provide a complete medical description of the images, including the dimensions of the embryo or fetus, cardiac activity if present and visible, and the presence of external members and internal organs if present and viewable. Providers are subject to civil actions and penalties for violations. The bill's ultrasound requirements do not apply in cases where a physical disorder, illness, or injury caused by the pregnancy endangers a woman's life. A woman is also not required to view the ultrasound images; nor may she or the provider be penalized if she declines to do so.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 541
In committee · Delaware House · Co-sponsor
Defund Planned Parenthood Act of 2021

Defund Planned Parenthood Act of 2021 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.

In committee Feb 2, 2021 1 co-sponsor
Co-sponsor HR 554
In committee · Delaware House · Co-sponsor
SAVE Moms and Babies Act of 2021

Support And Value Expectant Moms and Babies Act of 2021 or the SAVE Moms and Babies Act of 2021 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

In committee Feb 2, 2021 1 co-sponsor
Showing 1,241 to 1,250 of 1,259 bills